Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa - PubMed (original) (raw)

. 2010 Feb 19;327(5968):1010-3.

doi: 10.1126/science.1182749.

Peter Jetter, Bernhard J Ueberbacher, Martina Werneburg, Katja Zerbe, Jessica Steinmann, Benjamin Van der Meijden, Francesca Bernardini, Alexander Lederer, Ricardo L A Dias, Pauline E Misson, Heiko Henze, Jürg Zumbrunn, Frank O Gombert, Daniel Obrecht, Peter Hunziker, Stefan Schauer, Urs Ziegler, Andres Käch, Leo Eberl, Kathrin Riedel, Steven J DeMarco, John A Robinson

Affiliations

Free article

Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa

Nityakalyani Srinivas et al. Science. 2010.

Free article

Abstract

Antibiotics with new mechanisms of action are urgently required to combat the growing health threat posed by resistant pathogenic microorganisms. We synthesized a family of peptidomimetic antibiotics based on the antimicrobial peptide protegrin I. Several rounds of optimization gave a lead compound that was active in the nanomolar range against Gram-negative Pseudomonas spp., but was largely inactive against other Gram-negative and Gram-positive bacteria. Biochemical and genetic studies showed that the peptidomimetics had a non-membrane-lytic mechanism of action and identified a homolog of the beta-barrel protein LptD (Imp/OstA), which functions in outer-membrane biogenesis, as a cellular target. The peptidomimetic showed potent antimicrobial activity in a mouse septicemia infection model. Drug-resistant strains of Pseudomonas are a serious health problem, so this family of antibiotics may have important therapeutic applications.

PubMed Disclaimer

Comment in

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources